Benefiting from the super-rich valuations offered by Siemens Healthineers for the proposed acquisition of Varian Medical, Elekta, a direct competitor, surged c.15% yesterday. With the No.1 player in the oligopolistic radiation therapy market now grabbed, there is a possibility that the No.2 player, Elekta, might also be grasped by an industry bigwig. In our view, Royal Philips, which has been a strategic partner for Elekta, might be interested in the family-owned business in the mid-term.

04 Aug 2020
Can the Varian Healthineers deal ignite acquisitive interest in Elekta?

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Can the Varian Healthineers deal ignite acquisitive interest in Elekta?
Elekta AB Class B (EJXB:FRA) | 0 0 0.5% | Mkt Cap: 27,040m
- Published:
04 Aug 2020 -
Author:
Sumit Sayal -
Pages:
2 -
Benefiting from the super-rich valuations offered by Siemens Healthineers for the proposed acquisition of Varian Medical, Elekta, a direct competitor, surged c.15% yesterday. With the No.1 player in the oligopolistic radiation therapy market now grabbed, there is a possibility that the No.2 player, Elekta, might also be grasped by an industry bigwig. In our view, Royal Philips, which has been a strategic partner for Elekta, might be interested in the family-owned business in the mid-term.